Member Info for Bladderman

I was aiming to return between first sales and EUA. I have so hopefully timed perfectly!

NYCT product is 80% sensitive. Diagnostic labs are having to retest some samples as a consequence. GDR is 99% so the real deal.

As the Ask is thinking all the time

Great entry price

Lovely rise into close.

Spotted at £38k roll over buy at 6.23p - nice
Charge to 7p plus on monday

Achieved the 3 test milestone tests in partnership with Cytiva. Was CE marked. Now US and Indian approvals a formality as this t3st will present the new efficient and effective gold standard

July and August should provide decent SP rises

I need to get I to AIM management - I'd be great at that lifestyle lol

Either you sold out at the bottom or you been hitting the sauce to early today.

Which ever I'm not bothered!

Now with improved end point software to improve the user experience - that is a nice bonus

That's only £50M.

Which is a low valuation in the Hep C and COVID space

With £8M he should invest in the best sales team.

Sellers who wanted to sell have sold and moved on. Lots of new money in. Can see this back at 1p next week in anticipation of approvals

I wouldn't have a short open biscuit when the approvals land

What about the Indian and African markets?

US population is 330M and they are desperate to test.

Looks like money snapping up the cheap shares and MMs can't get people to sell below 80p. Better take it up then....

Seriously - lower than where we started.

Shares suck

Seriously - lower than where we started.

AIM sucks

I mean until the bid was sold into

It did u til the Ask was sold in to

Back to 1p+ looking at L2

Nice to see all MMs at 90p plus apart from what's it's face

Government bodies can't commit to sales of a product that isn't certified yet. Simples.

That's why we are waiting reg approval to do so. Then the distributors and sales team can push!